Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 29 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 2 2 2 3 3 3 4 3 4 4 5 5 5 5 5 6 7 27 A vi e nt A vi e nt ( E xc l. D is t. ) K W R P P G A V Y F U L R P M G C P H X L F M C H U N IF F E C L A S H K R A E M N C E S C L A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of July 28, 2021 Avient reflects 2021 estimated revenue of $4,650M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. We will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive long-term revenue growth in excess of GDP o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends in line with earnings growth and opportunistically buying back shares, all while remaining modestly levered.

Products manufactured on different com- pounding lines also have unique processing conditions, including but not limited to variations in screw design, residence time, and processing temperatures. For a base- line understanding, ZPT was compounded into these aforementioned products at nominal loading levels rang- ing from 1000–3000 ppm. Notably, the addition of blue tint can effectively decrease the YI to a level below FIGURE 2 Results of Japanese Industrial Standard Z2801 testing for various GLS™ thermoplastic elastomer line products; 24-h bacteria viability reported in mean CFU/sample is plotted for a series of samples with increased ZPT loading.

The revolving credit facility has a U.S. and a Canadian line of credit. The Company maintains a credit line with Saudi Hollandi Bank for $16.0 million. The revolving credit facility has a U.S. and a Canadian line of credit.

The revolving credit facility has a U.S. and a Canadian line of credit. The Company also has a credit line of $16.0 million with Saudi Hollandi Bank. The revolving credit facility has a U.S. and a Canadian line of credit.

Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 22 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 1 2 3 3 3 4 3 3 5 5 5 5 6 8 A vi e nt A vi e nt ( E xc l. D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of October 25, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. We will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Color revenue synergies, that will drive long-term revenue growth in excess of GDP o Clariant color cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends in line with earnings growth and opportunistically buying back shares, all while remaining modestly levered.

On the other hand, TPEs are most commonly processed using in-line, single- screw injection equipment that has been routinely used in the plastics industry for decades. Source: https://en.wikipedia.org/wiki/UV_degradation Consider UV exposure when designing exterior applications, such as window seals and high-voltage line insulators, or items that will be exposed to UV sterilization processes. The results were impressive: • Better tension set, improved compression and enhanced permeability • Slashed $70,000 from production costs by reducing cycle times and eliminating assembly steps • Lower specific gravity of TPEs trimmed overall part weight, which cut $36,000 in annual freight costs • Reprocessability of TPEs shrank scrap rates, saving more than $70,000 in material waste SWITCH TO TPEs BOOSTS BOTTOM LINE CASE STUDY READ MORE ONLINE For a manufacturer seeking to redesign a liquid injection-molded silicone medical pump valve insert, Avient suggested custom-formulated grades of Dynalloy™ OBC and Versaflex™ TPEs that would deliver better multi-functional performance than the previous design, while also facilitating easier two-shot molding. https://www.avient.com/idea/sealing-medical-device-savings APPLICATIONS LSR TPEs INFANT CARE • Pacifier • Baby bottle nipples • Breast pumps • Breast shields • Cup valves MEDICAL • Catheter • Tubing • Syringe seals • Respiratory masks • Handles/grips on surgical instruments • Prosthetics • Needleless valves • Gaskets • Valves • Wound drain bulb • Wound drain • Wound covering HOUSEHOLD • Bake ware (cake or muffin mold) • Oven gloves • Ice cube tray • Kitchen utensils • Trivet • Storage tubs RECREATION • Sporting goods (dive mask, protective mouthguard) • Shoe inserts AUTOMOTIVE • Turbocharge hoses • Radiator hoses • Spark plug boots • Underhood seals + gaskets • Interior seals + gaskets • Interior HVAC flaps ELECTRIC + ELECTRONICS • High voltage insulators • Wire + cable coating • Cellphone cases • Fitness wearables RETAIL • Packaging • Blister packs What’s the best fit for your application?

Microsoft Word - Avient Announces First Quarter 2025 Results 1 NEWS RELEASE FOR IMMEDIATE RELEASE Avient Announces First Quarter 2025 Results • First quarter sales of $827 million, reflects 2% organic growth over the prior year quarter, excluding the impact of foreign exchange • First quarter GAAP EPS of ($0.22) compared to $0.54 in the prior year quarter • First quarter adjusted EPS of $0.76, in-line with guidance; growth of 4% over the prior year quarter, excluding an unfavorable impact of $0.03 from foreign exchange • 2025 full year adjusted EPS guidance range of $2.70 to $2.94, unchanged from prior guidance CLEVELAND – May 6, 2025 – Avient Corporation (NYSE: AVNT), an innovator of materials solutions, today announced its first quarter results for 2025. However, our current operational performance is in-line with expectations, and we are keeping our full year guidance range unchanged for adjusted EBITDA of $540 to $570 million and adjusted EPS of $2.70 to $2.94. We see opportunity to differentiate our performance by executing our strategy and remain committed to organically grow above our markets while expanding margins on the bottom line.”

On the bottom line, adjusted EBITDA margins expanded 30 basis points to 17.2%. We remain committed to executing our strategy to drive top line growth above our markets, while expanding margins on the bottom line.”

The poles have an excellent dielectric strength that allows for safer installation near energized lines.

The optimized, unique metering unit is carried by our Technical Representatives in a shoulder bag, resulting in a no-fuss approach that allows trials to take place with minimal disruption and to confirms the operability of FlexOne and Avient products on your production line.